BioInsights - New horizons for cell therapy: emerging platforms - spotlight

CELL & GENE THERAPY INSIGHTS

New horizons for cell therapy: emerging platforms

October 2021
New horizons for cell therapy: emerging platforms
Download PDF

Editorial

A model for where we live

A model for where we live

Jared Burks
25 November 2021
Read
Mass cytometry for comprehensive immune profiling in CAR T cell

Mass cytometry for comprehensive immune profiling in CAR T cell

Sneha Ramakrishna
18 November 2021
Read
Engineering new killers: bringing NK cells to the battle against cancer

Engineering new killers: bringing NK cells to the battle against cancer

T Laskowski, S Acharya, M Shanley
17 November 2021
Read
Full spectrum flow cytometry: a powerful cytometric analysis to benefit cell therapy

Full spectrum flow cytometry: a powerful cytometric analysis to benefit cell therapy

Ana Leda Figueiredo Longhini
10 November 2021
Read

Expert Insight

Artificial intelligence: accelerating translational cell therapy development through computational methods for neoepitope discovery

Artificial intelligence: accelerating translational cell therapy development through computational methods for neoepitope discovery

M Chiriva-Internati, L Piccotti, L Zammataro et al.
25 November 2021
Read
Next-generation DNA vectors: is the nS/MARt platform a viable alternative to viruses for autologous T-cell immunotherapy?

Next-generation DNA vectors: is the nS/MARt platform a viable alternative to viruses for autologous T-cell immunotherapy?

Matthias Bozza, Richard Harbottle
23 November 2021
Read

Interview

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

D Corey, J Rossi, R Vezan
25 November 2021
Read
Critical success factors for tomorrow’s cellular immunotherapies

Critical success factors for tomorrow’s cellular immunotherapies

Peter Emtage
17 November 2021
Read
A question of control? Next steps for novel TIL therapeutics

A question of control? Next steps for novel TIL therapeutics

Jan ter Meulen MD PhD
17 November 2021
Read
Enhancing the depth and durability of patient responses to CAR T cell therapy

Enhancing the depth and durability of patient responses to CAR T cell therapy

Jennifer Brogdon
17 November 2021
Read

Podcast

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

25 November 2021
Listen

Expert Roundtable Video

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

I Riviére, M Kurtoglu, T Haq
22 November 2021
Watch

Expert Roundtable

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

Tariq Haq
22 November 2021
Read